Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature review

INTRODUCTION: Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad antifungal cover and favorable side effect profile but, notably, it has no activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Louis-Auguste, John R., Micallef, Christianne, Ambrose, Tim, Upponi, Sara, Butler, Andrew J., Massey, Dunecan, Middleton, Stephen J., Russell, Neil, Rutter, Charlotte S., Sharkey, Lisa M., Woodward, Jeremy, Gkrania-Klotsas, Effrossyni, Enoch, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010962/
https://www.ncbi.nlm.nih.gov/pubmed/29942755
http://dx.doi.org/10.1016/j.idcr.2018.03.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010962/
https://www.ncbi.nlm.nih.gov/pubmed/29942755
http://dx.doi.org/10.1016/j.idcr.2018.03.017

Ejemplares similares